On September 9, 2026, clinical groups in the UK reviewed access pathways for importing unlicensed specialty medicines. The Medicines and Healthcare products Regulatory Agency (MHRA) permits the importation of unlicensed medicines to satisfy the clinical needs of individual patients when licensed alternatives are not available in the UK market.

At Onco Medicine, we specialize in delivering authentic, batch-verified specialty medications directly to pharmacies, clinics, and patients in the UK.

Accessing Unlicensed Specialty Medicines

Sourcing unlicensed specialty medications into the UK involves the following requirements:

• Clinical Necessity: The medicine must be prescribed by a UK-licensed clinician who assumes responsibility for using an unlicensed product.
• MHRA Compliance: Imports must be for personal use or managed under the MHRA's notification scheme for clinics.
• Traceability: Every shipment includes batch Certificate of Analysis (COA) and temperature control records.

For support, contact us at support@onco-medicine.com or WhatsApp WhatsApp +91 94275 19809.